Roche Holding AG (RHHVF)
244.00
+10.73
(+4.60%)
USD |
OTCM |
May 07, 15:55
Roche Market Cap: 194.53B for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 185.97B |
| May 03, 2024 | 189.18B |
| May 02, 2024 | 187.59B |
| May 01, 2024 | 188.15B |
| April 30, 2024 | 190.38B |
| April 29, 2024 | 191.43B |
| April 26, 2024 | 193.22B |
| April 25, 2024 | 189.52B |
| April 24, 2024 | 192.54B |
| April 23, 2024 | 199.94B |
| April 22, 2024 | 195.47B |
| April 19, 2024 | 194.51B |
| April 18, 2024 | 191.39B |
| April 17, 2024 | 193.43B |
| April 16, 2024 | 194.13B |
| April 15, 2024 | 194.91B |
| April 12, 2024 | 195.25B |
| April 11, 2024 | 197.16B |
| April 10, 2024 | 195.81B |
| April 09, 2024 | 195.01B |
| April 08, 2024 | 193.15B |
| April 05, 2024 | 193.36B |
| April 04, 2024 | 196.60B |
| April 03, 2024 | 199.50B |
| April 02, 2024 | 199.32B |
| Date | Value |
|---|---|
| April 01, 2024 | 201.23B |
| March 28, 2024 | 204.22B |
| March 27, 2024 | 201.22B |
| March 26, 2024 | 199.47B |
| March 25, 2024 | 201.67B |
| March 22, 2024 | 199.97B |
| March 21, 2024 | 200.35B |
| March 20, 2024 | 207.30B |
| March 19, 2024 | 206.53B |
| March 18, 2024 | 205.41B |
| March 15, 2024 | 209.18B |
| March 14, 2024 | 210.63B |
| March 13, 2024 | 217.09B |
| March 12, 2024 | 222.74B |
| March 11, 2024 | 217.49B |
| March 08, 2024 | 216.19B |
| March 07, 2024 | 213.90B |
| March 06, 2024 | 213.82B |
| March 05, 2024 | 212.54B |
| March 04, 2024 | 208.98B |
| March 01, 2024 | 209.28B |
| February 29, 2024 | 207.68B |
| February 28, 2024 | 209.81B |
| February 27, 2024 | 210.49B |
| February 26, 2024 | 204.89B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
185.97B
Minimum
May 06 2024
356.53B
Maximum
Dec 29 2021
270.15B
Average
266.60B
Median
Market Cap Benchmarks
| AC Immune SA | 235.38M |
| CRISPR Therapeutics AG | 4.714B |
| Addex Therapeutics Ltd | 9.780M |
| NLS Pharmaceutics Ltd | 5.978M |
| Molecular Partners AG | 116.63M |
Market Cap Related Metrics
| PE Ratio | 15.24 |
| PS Ratio | 2.897 |
| Price to Book Value | 5.574 |
| Price to Free Cash Flow | 15.30 |
| Price | 244.00 |
| Earnings Yield | 6.56% |
| Operating PE Ratio | 11.39 |
| Normalized PE Ratio | 15.07 |